Implementation of Diabetes Mellitus Program in the Tyumen region

Aim. To assess results of realization of the regional Diabetes Mellitus Program in the Tyumen region. Materials and methods. Materials of the regional Diabetes Mellitus Registry for 1999-2007 were analysed. Results. DM1 and DM2 morbidity increased from 6.6 to 8.16 and from 97.3 to 216.96 per...

Full description

Bibliographic Details
Main Authors: Lyudmila Alexandrovna Suplotova, L N Belchikova, N S Brynza
Format: Article
Language:English
Published: Endocrinology Research Centre 2009-03-01
Series:Сахарный диабет
Subjects:
Online Access:https://dia-endojournals.ru/dia/article/viewFile/5418/3217
id doaj-bb910a1413bd4c57879ef0c8c29bdc77
record_format Article
spelling doaj-bb910a1413bd4c57879ef0c8c29bdc772021-06-02T21:12:23ZengEndocrinology Research CentreСахарный диабет2072-03512072-03782009-03-01121333510.14341/2072-0351-54185376Implementation of Diabetes Mellitus Program in the Tyumen regionLyudmila Alexandrovna Suplotova0L N Belchikova1N S Brynza2ГОУ ВПО ТюмГМА Росздрава, Тюмень; ГЛПУ «Тюменская областная клиническая больница», ТюменьГОУ ВПО ТюмГМА Росздрава, Тюмень; ГЛПУ «Тюменская областная клиническая больница», ТюменьГОУ ВПО ТюмГМА Росздрава, Тюмень; ГЛПУ «Тюменская областная клиническая больница», ТюменьAim. To assess results of realization of the regional Diabetes Mellitus Program in the Tyumen region. Materials and methods. Materials of the regional Diabetes Mellitus Registry for 1999-2007 were analysed. Results. DM1 and DM2 morbidity increased from 6.6 to 8.16 and from 97.3 to 216.96 per100,000 population respectively. Primary disability rate among DM1 and DM2 patientsdecreased by a factor of 2. The fraction of patients with severe diabetic complications also decreased (1.3 times for blindness, 1.8 times for amputations). The frequency of diabeticcoma decreased by a factor of 2. Thirty five Diabetes School were organized. Mean life expectancy of DM1 and DM2 subjects increased from 49.55?5.43 to 50.11?2.96 years(p = 0.0001) and from 68.00?1.79 to 71.52?0.39 years (r = 0.0001) respectively. Mortality rate in DM1 and DM2 patients dropped by a factor of 5 and 3. All DM patients use onlymodern insulin formulations, with analogs accounting for 39.5% and human recombinant insulins for the rest of the total. Therapeutic use of secretagogues for the managementof DM2 decreased from 84.8 to 49.1% (p = 0.0001) and that of metformin increased form 6.8 to 28% (p = 0.0001); the need in insulin therapy also increased. Conclusion. Elaboration and implementation of the program contributed to the decreased occurrence of diabetic coma, blindness, and amputations in DM1 and DM2 patients,their longer life expectancy, and improved availability of high-quality oral hypoglycemic agents.https://dia-endojournals.ru/dia/article/viewFile/5418/3217diabetes mellitusregional registrymorbiditydisabilitycomplicationsmortality
collection DOAJ
language English
format Article
sources DOAJ
author Lyudmila Alexandrovna Suplotova
L N Belchikova
N S Brynza
spellingShingle Lyudmila Alexandrovna Suplotova
L N Belchikova
N S Brynza
Implementation of Diabetes Mellitus Program in the Tyumen region
Сахарный диабет
diabetes mellitus
regional registry
morbidity
disability
complications
mortality
author_facet Lyudmila Alexandrovna Suplotova
L N Belchikova
N S Brynza
author_sort Lyudmila Alexandrovna Suplotova
title Implementation of Diabetes Mellitus Program in the Tyumen region
title_short Implementation of Diabetes Mellitus Program in the Tyumen region
title_full Implementation of Diabetes Mellitus Program in the Tyumen region
title_fullStr Implementation of Diabetes Mellitus Program in the Tyumen region
title_full_unstemmed Implementation of Diabetes Mellitus Program in the Tyumen region
title_sort implementation of diabetes mellitus program in the tyumen region
publisher Endocrinology Research Centre
series Сахарный диабет
issn 2072-0351
2072-0378
publishDate 2009-03-01
description Aim. To assess results of realization of the regional Diabetes Mellitus Program in the Tyumen region. Materials and methods. Materials of the regional Diabetes Mellitus Registry for 1999-2007 were analysed. Results. DM1 and DM2 morbidity increased from 6.6 to 8.16 and from 97.3 to 216.96 per100,000 population respectively. Primary disability rate among DM1 and DM2 patientsdecreased by a factor of 2. The fraction of patients with severe diabetic complications also decreased (1.3 times for blindness, 1.8 times for amputations). The frequency of diabeticcoma decreased by a factor of 2. Thirty five Diabetes School were organized. Mean life expectancy of DM1 and DM2 subjects increased from 49.55?5.43 to 50.11?2.96 years(p = 0.0001) and from 68.00?1.79 to 71.52?0.39 years (r = 0.0001) respectively. Mortality rate in DM1 and DM2 patients dropped by a factor of 5 and 3. All DM patients use onlymodern insulin formulations, with analogs accounting for 39.5% and human recombinant insulins for the rest of the total. Therapeutic use of secretagogues for the managementof DM2 decreased from 84.8 to 49.1% (p = 0.0001) and that of metformin increased form 6.8 to 28% (p = 0.0001); the need in insulin therapy also increased. Conclusion. Elaboration and implementation of the program contributed to the decreased occurrence of diabetic coma, blindness, and amputations in DM1 and DM2 patients,their longer life expectancy, and improved availability of high-quality oral hypoglycemic agents.
topic diabetes mellitus
regional registry
morbidity
disability
complications
mortality
url https://dia-endojournals.ru/dia/article/viewFile/5418/3217
work_keys_str_mv AT lyudmilaalexandrovnasuplotova implementationofdiabetesmellitusprograminthetyumenregion
AT lnbelchikova implementationofdiabetesmellitusprograminthetyumenregion
AT nsbrynza implementationofdiabetesmellitusprograminthetyumenregion
_version_ 1721400859340832768